Heritage Cann ehemals Umbral Energy

So, fange mal an.
Aktie wird wohl nach der Freigabe schön nach Oben laufen.  

Hier wird bald die Post abgehen...
Kurs um 0,20 Euro-Cent werden bald Vergangenheit sein. Mal sehen was heute in CAN so passiert.
Mein Fuß steht bereits in der Tür - und freu mich auf Kurse jenseits von 1-2-3 Euro die nächsten Monate
:-)

 

Beobachte die Aktie schon eine Weile, endlich ist die Freigabe da, hat lange genug gedauert.
Vorhin an der CAN-Börse nach dem Halt im ersten "Dip" zugeschlagen. Jetzt lassen wir das mal ein Weilchen liegen.

Bisher kaum beachtet in Deutschland. Find ich gut so, dann bleibt der Kurs bei den Holzfällern ;-)  

Na dann schauen wir mal, was da kommt...  

Die letzten Monate ging es nach einem starken Abverkauf kontinuierlich nach oben, nun kommen wir in eine spannende Phase. Gerüchten zufolge steht noch einiges in der Pipeline, neben Investoren warten Aktionäre auf weitere Cannabis-Lizensen (u.a. Öle, CBD).

Meiner Meinung nach haben wir hier noch nicht die "Decke" erreicht :-)
Das Volumen der letzten drei Tagen war in Kanada sehr hoch, 2x 4 Mio und 1x 8 Mio gehandelte Stücke.

Wer Interesse daran hat, kann sich gerne hier schlauer machen: https://ceo.ca/cann
 

https://ceo.ca/@thenewswire/heritage-reports-first-cannabis-harvest

Vancouver, B.C. / TheNewswire / January 29, 2019 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is excited to announce the commencement of it’s first cannabis harvest at the Fort Erie location of its subsidiary CannaCure Corporation (“CannaCure”).


As previously announced on November 14, 2018, CannaCure signed an agreement with CannTrust Inc. (TSX:TRST) (“CannTrust”), which provided the original genetics for this inaugural grow.  The agreement calls for CannTrust having a right of first refusal to purchase the product from CannaCure.


“We’re proud to share this important milestone with our community, stakeholders and industry partners.  This harvest signals our advancement in our production objectives and our continuous growth within cannabis industry.  I would like to thank our cultivation team who worked hard over these past 10 weeks, including the holidays, to ensure our first crop was a success” states Clint Sharples, Chairman and interim CEO.  “We are on schedule to meet our 2019 production targets and expect multiple successful harvests in the coming months when CannaCure and PhyeinMed are producing at full capacity.”


As a result of the success of the first harvest, CannaCure intends on rolling immediately into their second grow, utilizing the same genetics as the original crop.  Plants are scheduled to be introduced into the grow room environment within the next few weeks.  

https://ceo.ca/@thenewswire/...oins-heritage-as-chairman-of-the-board

Vancouver, B.C. / TheNewswire / February 4, 2019 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is pleased to announce the appointment of Mr. Donald Ziraldo, as Chairman to the board of directors. In addition, Heritage is delighted to officially announce Mr. Clint Sharples as the permanent Chief Executive Officer (“CEO”). The Heritage team continues grow in strength and leadership with the addition of Donald Ziraldo and appointment of Clint Sharples as CEO.


“Heritage is fortunate to have Donald Ziraldo join our board and take on the position of Chairman. His past successes in business, his experience dealing with regulatory bodies and his knowledge of Canadian liquor boards will all be valuable to us.” says Clint Sharples, CEO of Heritage “I look forward to continuing as the official CEO of Heritage as we build a team to take us forward.”


Mr. Ziraldo’s passion and determination have been a central force in the emerging success of the Canadian wine industry. As co-founder of the Inniskillin winery in Niagara-On-TheLake, Ziraldo was granted the first winery license in Ontario after prohibition. His talent and perseverance have helped to make Canadian icewine a globally recognized luxury brand. A dedicated ambassador of Canadian wines, Ziraldo was founding chair of the Vintner’s Quality Alliance (VQA), Canada’s regulatory agency responsible for maintaining the integrity of local wine appellations. Among his many acknowledgments, he holds an honorary degree from both Brock University and University of Guelph and is a Member of the Order of Canada. He was named one of the top twenty-five Canadian CEO’s of the Century by the National Post Magazine. Ziraldo continues to be hailed as one of the most important figures in Canadian wine history. For more information on Donald Ziraldo visit www.ziraldo.ca.


“I’m excited to join the Heritage team and continue driving their strategic objectives forward,” said Donald Ziraldo. “The cannabis market presents a significant growth opportunity similar to the wine industry and Heritage is well-positioned to establish a strong leadership position in this quickly evolving market.”.  

https://ceo.ca/@thenewswire/heritage-orders-three-extraction-systems

Vancouver, B.C. / TheNewswire / February 5, 2019 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is pleased to announce the expansion of its extraction capacity with the order of three new Vitalis extraction systems, expected to be delivered before the end of February 2019.


This order will see two new units to be delivered to CannaCure Corp (“CannaCure”) in Fort Erie, ON, and one new unit to be installed in addition to the Company’s existing extraction unit at Falkland, BC in the PhyeinMed Inc. (“PhyeinMed”) location. Once installation of all four systems are completed, and the necessary licenses from Health Canada are obtained, Heritage will become one of the largest processing companies in Canada in terms of extraction capacity.


“The team at Heritage continues to execute our business plan, driving our company forward towards our ultimate goal of becoming a fully integrated, industry leader in the Canadian cannabis industry.” states Clint Sharples, CEO of Heritage “The expertise we acquired from Purefarma Solutions in December has allowed us to expedite extraction plans and will enable us to achieve our revenue goals set for Q2.”


The Company expects the installation of these units at CannaCure and PhyeinMed to be completed by the end of March 2019.  

https://ceo.ca/@thenewswire/heritage-names-new-cfo

Vancouver, B.C. / TheNewswire / February 7, 2019 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) are pleased to announce the addition of Erin Prohaska, CA, CPA, to the Executive Leadership team. Erin will join the team as the Company's Chief Financial Officer.


Ms. Prohaska has an extensive career leading finance and operations teams in diverse industries. Prior to joining Heritage, Erin was the CFO of a multinational consulting engineering firm with over 2500 employees. Prior to this, she managed and advised notable Family Offices on their finances and business holdings, including venture capital funds. Her career started at Deloitte, where she advised clients on both domestic and international tax issues. While working at Deloitte, Erin also earned her Masters degree in Taxation.  


“A priority of the company has been to strengthen our leadership team. Recent changes to the board in conjunction with these critical additions to our executive team, shows that Heritage is preparing itself for our expected future growth.” said Clint Sharples, CEO of Heritage. “The addition of Erin allows for our other Executives and business units to focus on executing our plan.”


The Company would like to express our very sincere thanks to Kristina Khersonski for the work she has done for Heritage over the past few years, and we wish her all the best in the future.  

www.midasletter.com/19/02/...corp-cnsxcann-and-the-40m-press-release/  

https://ceo.ca/@thenewswire/...age-launches-medical-cannabis-division

Vancouver, B.C. / TheNewswire / February 25, 2019 – HERITAGE CANNABIS HOLDINGS CORP. (CSE: CANN) (“Heritage” or “Company”) is pleased to announce the addition of BriteLife Sciences Ltd. (“BriteLife”), a newly formed wholly owned subsidiary dedicated to furthering the Company’s footprint in the medical cannabis market.


This new subsidiary will look to introduce various medical related propriety branded products and partnerships with other recognized industry leaders. Dr. Chris Spooner, Heritage’s Chief Science Officer, will oversee the strategic direction while Cyndi McLean will take the role as Vice President of Business Development for BriteLife, responsible for sales and client relationship management.


“Developing a strong focus on the medical cannabis market has always been one of the pillars of our overall corporate growth strategy.” says Debra Senger, Heritage’s Chief Strategy Officer. “Having the right people in place has allowed us to expand our plans to include many options which were previously unavailable to us.”


BriteLife will have the advantage of drawing from Dr. Spooner’s and Ms. McLean’s medical networks and years of experience in the pharmaceutical and medical cannabis market. The division will include a significant educational component targeted at assisting patients with individualized custom solutions.


“Launching BriteLife is an important accomplishment for our strategy team. We expect that it will expand our markets and introduce new and creative ways for us to reach medical cannabis patients.” states Clint Sharples, CEO of Heritage “The exclusive modifications that we have incorporated into our existing extraction methods allow us to easily isolate a few of the less known therapeutic cannabis components which can be used in our medial product lines.”  

http://cdn.ceo.ca.s3-us-west-2.amazonaws.com/...9013-03C79D78FDEF.png

https://www.canada.ca/en/health-canada/services/...ssors-sellers.html

Nach PhyeinMed Inc. suchen. Das wird ein lustiger Start in die neue Woche ;-)) Mal sehen, ob auch welche aus Deutschland einsteigen. Bisher bei uns kaum bekannt.

Neben dieser Lizenz wird auch noch die von Cannacure erwartet. Wilde Zeiten stehen bevor.  

https://twitter.com/heritagecannab/status/1101609824523972608?s=21

"Congratulations to our amazing partner @PhyeinMed on receiving its Standard Processing license AND Medical Sales License today from Health Canada under the Cannabis Act!  We're just getting started folks!"

 

https://twitter.com/clintsharples/status/1101617067436855296?s=19

Not sure if anyone noticed, but today @PhyeinMed got not only it's PROCESSING licence, but also our MEDICAL SALES licence putting us four months ahead of plan!! Our Chief Strategy Officer Debra Senger deserves a huge high five! $cann $cann.c

 

nun sind gleich beide Lizenzen da,super das wird den Kurs befeuern denke ich,auf WO wird darüber schon diskutiert  

https://www.newcannabisventures.com/...lead-index-higher-in-february/

Herritage Cannabis unter "Tier 3"

"Tier 3, which included the 36 LPs that generate quarterly sales less than C$2.5 million, rose 4.0%, leaving its year-to-date gain at 36.0% after declining 26.4% in 2018. The best performers in the group were Heritage Cannabis (CSE: CANN) (OTC: HERTF), MediPharm Labs (TSXV: LABS) (OTC: MLCPF) and 48North (TSXV: NRTH) (OTC: NCNNF), all of which gained more than 50%. Heritage, relatively unknown, became more visible after completing a recent capital raise, making several announcements regarding its operations and additions to its management team. MediPharm Labs announced a very large contract during the month to provide extraction services to a large LP. 48North reported strong revenue growth with positive operating cash flow in late February and also signed a supply agreement with Quebec, the first LP to do so with outdoor grown cannabis. 16 of the 17 worst performers for the month were part of Tier 3.

The returns for the overall sector varied greatly, with six names gaining more than 20%, while five declined by more than 20%:"  

https://ceo.ca/@thenewswire/...ry-awarded-standard-processing-license

" Vancouver, B.C. / TheNewswire / March 4, 2019 – HERITAGE CANNABIS HOLDINGS CORP.(CSE: CANN) (“Heritage” or “Company”) is pleased to announce that its subsidiary PhyeinMed Inc. (“PhyeinMed”) has received both its Standard Processing Licence and Medical Sales Licence from Health Canada.


Effective immediately, PhyeinMed will initiate the process of receiving over 50,000 kg of hemp feed stock utilizing the two Vitalis Q90 extraction systems which were recently installed in their Falkland, British Columbia facility. The extraction systems will be operated by the skilled and experienced professionals from Purefarma Solutions (“Purefarma”). The proprietary process methods are expected to produce top quality oils on a consistent basis.


This processing licence will give PhyeinMed the opportunity to engage with other Licensed Producers under toll processing agreements for both white label and branded extracted products.


In addition to the processing licence, PhyeinMed has been granted its Medical Sales Licence. The company is now able to provide medical education services and sell directly to patients who have a medical document to use cannabis for medical purposes. PhyeinMed is working with BriteLife Sciences (“BriteLife”) to create proprietary formulations utilizing industry research and the experience of Dr Chris Spooner, Chief Science Officer of the corporation.


“We are extremely pleased to see PhyeinMed awarded these two very important licences. This allows our company to stay on track with our plans for extraction, but also accelerates our plans for our medical cannabis sales.” said Clint Sharples, CEO of Heritage “I’m very pleased with how our team continues to execute our business plan. We are eager to move quickly to revenue, and look forward to proving ourselves as being among the leaders for extraction services in Canada.”


The initial portion of Purefarma’s hemp feedstock stockpiled in Saskatchewan has been shipped to PhyeinMed and the Purefarma technicians will begin extracting immediately upon the product arriving. Once the oil is produced, it will be sent to independent labs for testing, and the Company will receive a final inspection from Health Canada, before it is sold. "  

Vancouver, B.C. / TheNewswire / 4. März 2019 - HERITAGE CANNABIS HOLDINGS CORP.(CSE: CANN) ("Heritage" oder "Company") freut sich bekannt zu geben, dass ihre Tochtergesellschaft PhyeinMed Inc. ("PhyeinMed") hat sowohl seine Standard-Verarbeitungslizenz als auch seine medizinische Vertriebslizenz von Health Canada erhalten.


Mit sofortiger Wirkung wird PhyeinMed den Prozess der Annahme von über 50.000 kg Hanfrohstoff mit den beiden Vitalis Q90-Extraktionssystemen einleiten, die kürzlich in ihrer Anlage in Falkland, British Columbia, installiert wurden. Die Extraktionssysteme werden von den qualifizierten und erfahrenen Fachleuten von Purefarma Solutions ("Purefarma") betrieben. Von den proprietären Prozessmethoden wird erwartet, dass sie Öle von höchster Qualität auf konsistenter Basis produzieren.


Diese Verarbeitungslizenz gibt PhyeinMed die Möglichkeit, mit anderen Lizenzproduzenten im Rahmen von Lohnverarbeitungsverträgen für White-Label- und Markenprodukte zusammenzuarbeiten.


Zusätzlich zur Verarbeitungslizenz hat PhyeinMed die Medical Sales Licence erhalten. Das Unternehmen ist nun in der Lage, medizinische Bildungsdienstleistungen anzubieten und direkt an Patienten zu verkaufen, die ein medizinisches Dokument haben, um Cannabis für medizinische Zwecke zu verwenden. PhyeinMed arbeitet mit BriteLife Sciences ("BriteLife") zusammen, um eigene Formulierungen zu entwickeln, die auf Branchenforschung und der Erfahrung von Dr. Chris Spooner, Chief Science Officer des Unternehmens, basieren.


"Wir freuen uns sehr, dass PhyeinMed diese beiden sehr wichtigen Lizenzen erhalten hat. Dies ermöglicht es unserem Unternehmen, mit unseren Plänen für die Extraktion Schritt zu halten, beschleunigt aber auch unsere Pläne für den Verkauf von medizinischem Cannabis", sagte Clint Sharples, CEO von Heritage "Ich bin sehr zufrieden damit, wie unser Team unseren Geschäftsplan weiterhin umsetzt. Wir sind bestrebt, schnell zum Umsatz zu kommen und freuen uns darauf, uns als einer der führenden Anbieter von Extraktionsdienstleistungen in Kanada zu beweisen".


Der erste Teil der Hanfrohstoffe von Purefarma, die in Saskatchewan gelagert sind, wurde an PhyeinMed geliefert, und die Purefarma-Techniker werden sofort nach Ankunft des Produkts mit der Extraktion beginnen. Sobald das Öl produziert ist, wird es zur Prüfung an unabhängige Labors geschickt, und das Unternehmen erhält eine Endkontrolle von Health Canada, bevor es verkauft wird.

Übersetzt mit www.DeepL.com/Translator  

https://ceo.ca/@thenewswire/...ms-receive-manufacturing-certification

Vancouver, B.C. / TheNewswire / 5. März 2019 - HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) ("Heritage" oder "Company") freut sich, die installierten Absauganlagen bei der PhyeinMed Inc. bekannt zu geben. ("PhyeinMed") in Falkland, British Columbia, hat die Fertigungszertifizierung erhalten.


Die Extraktionsmaschinen wurden kalibriert und getestet und werden nun für die Aufnahme von getrocknetem Hanfrohstoff vorbereitet, um mit der Verarbeitung zu hochwertigem CBD-Öl zu beginnen. Die Zertifizierung von Vitalis garantiert, dass jedes Druckgerät den ASME- und CSA-Standards für Kessel, Druckbehälter und Druckleitungen entspricht und mit CRN- und NB-Registrierungsnummern als Bestätigung versehen ist. PhyeinMed-Extraktionsmaschinen durchlaufen vor dem Betrieb ebenfalls einen aufwändigen internen Inbetriebnahmeprozess.


"Da wir weiterhin in unser Wachstum investieren, könnte der Zeitpunkt nicht besser sein, um die Zertifizierung unserer Extraktionssysteme zu erhalten. Wir haben uns sehr gut positioniert, um die steigende Nachfrage nach raffinierten Konzentraten in Kanada bedienen zu können", sagte Clint Sharples, CEO von Heritage "Die Umsetzung unseres Businessplans steht weiterhin im Mittelpunkt unseres Unternehmens. Ein wichtiger Teil der Strategie ist die Extraktion unserer eigenen Produkte sowie das Angebot unserer Dienstleistungen für andere Lizenzproduzenten."

 

Charttechnisch sieht es momentan super aus!
https://www.tradingview.com/x/CgnunVPr/

Zudem könnte es heute abend (22 Uhr) die nächste Lizenz geben. Diesmal steht CannaCure an.
Falls nicht heute, dann höchstwahrscheinlich kommende Woche Freitag.

Anschnallen... :-))
 

https://twitter.com/kurtis_di/status/1110189997934575617?s=21

Die Woche wird interessant, Freitag 21 Uhr (CET) wissen wir mehr :o)  

Heute 22:00 Uhr zählt's!

Sollte tatsächlich die nächste Lizenz der Health Canada heute Abend folgen, wird es mutmaßlich kommende Woche zu einem ordentlichen Newsflow kommen.

https://www.canada.ca/en/health-canada/services/...ssors-sellers.html

Hier kann man ab 22:00 Uhr nachschauen, wer die Lizenz(en) diese Woche erhalten hat.

Habe heute ab 14:30 - 15:00 Uhr nochmal ordentlich nachgelegt. Hätte das auch schon Anfang Februar für die Hälfte tun können.. aber was solls. Auf geht's!  

Quartalsbericht auf SEDAR ist online:
https://www.sedar.com/...=03&projectNo=02894465&docId=4488067  

Lizenz ist da :-))))

Das wird lustig Montag  

Mit 2K rein. Hatte es gelesen bei WO im Forum von SE. Na ja, mal schauen ob ich etwas Glück habe, kommt mir meinem anderen Negativ Invest bis jetzt sehr entgegen